Maccura Biotechnology Co Stock Price To Earnings To Growth

300463 Stock   12.84  0.33  2.51%   
Maccura Biotechnology Co fundamentals help investors to digest information that contributes to Maccura Biotechnology's financial success or failures. It also enables traders to predict the movement of Maccura Stock. The fundamental analysis module provides a way to measure Maccura Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Maccura Biotechnology stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Maccura Biotechnology Co Company Price To Earnings To Growth Analysis

Maccura Biotechnology's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition

Based on the latest financial disclosure, Maccura Biotechnology Co has a Price To Earnings To Growth of 0.0 times. This indicator is about the same for the Life Sciences Tools & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all China stocks average (which is currently at 0.0).

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

Maccura Fundamentals

About Maccura Biotechnology Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Maccura Biotechnology Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maccura Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maccura Biotechnology Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Maccura Stock

Maccura Biotechnology financial ratios help investors to determine whether Maccura Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Maccura with respect to the benefits of owning Maccura Biotechnology security.